focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.52
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 82.52
EVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on COVID-19

16 Apr 2020 14:00

RNS Number : 9171J
Evraz Plc
16 April 2020
 

Update on COVID-19

 

16 April 2020 - EVRAZ plc ("EVRAZ or the "Group") today announces an update on the impact of COVID-19 on its business.

Group focus and priorities

The Group is closely monitoring the development of the COVID-19 pandemic and its impact on our employees, our operations and the broader stakeholder base. EVRAZ's immediate focus is on doing everything in its power to protect the lives and health of our employees and minimise the negative impact on our facilities and the communities in which we operate.

During and since March 2020, in response to the coronavirus pandemic the Group has introduced additional safety measures to protect its people and ensure continued operations.

These include:

· Significant reduction of domestic and cancellation of overseas business travel;

· Two-week isolation, with full salary, for all employees returning from trips abroad, either personal or work-related;

· Enabling remote working, provision of additional personal protection equipment for employees who must come to work, including eye protectors, respirators and gloves;

· Installation of thermal imaging devices and pyrometers at the entrances to our facilities to monitor people's temperatures;

· Elimination to the extent possible of large gatherings (with social distancing when they must take place), and cancellation of all major corporate, sporting and entertainment events;

· Increase of supplies of antiseptic and disinfectant products in communal areas, regular sanitation of facilities and transport;

· Campaigns to raise awareness among employees and contractors on behavioural features, social distancing and personal protection.

The Group is monitoring the spread of coronavirus and working with healthcare facilities and insurance organisations to take proactive decisions aimed at safeguarding its employees and their families. Currently there are no confirmed COVID-19 cases in EVRAZ.

Update on our operations and outlook 

The Group remains closely focused on its operations, including logistics, supply and technological processes. At present, EVRAZ is facing no significant issues with the production or supply of raw materials and other goods. Shipments continue, and raw material deliveries to enterprises are stable.

However, in the near term, we expect domestic steel demand to fall due to the significant economic down-turn that the restrictions imposed due to COVID-2019 are causing worldwide, including in Russia. This will, no doubt, affect firstly our construction products sales and then our railway products sales, to a slightly lesser extent.

We expect the impact on exports to be less significant. This is due to the recent rouble devaluation and EVRAZ's ability to redirect steel from domestic sales to export markets.

While the impact on the Group has been limited so far, we are likely to experience challenges in the near term. While our enterprises have been operating at full capacity, the situation is likely to be more complex in May and June. In the light of this, EVRAZ is working on a comprehensive package of optimisation measures that we expect to partially mitigate these negative effects.

Our financial position

The Group remains well capitalised with a strong liquidity cushion.

As at 31 December 2019, our net debt amounted to US$3,445 million. This reflected cash of US$1,423 million. Short-term loans and the current portion of long-term loans stood at US$140 million. Total scheduled debt maturities during 2020 will amount to no more thanUS$52 million.

In March 2020, EVRAZ paid interim dividends to its shareholders amounting to US$580.8 million, US$0.40 per share.

In addition, also in March 2020, EVRAZ signed a US$750 million 5-year committed syndicated unsecured credit facility. This facility was arranged and fully underwritten by a group of 10 international banks and is available for drawing until 18 March 2021. The proceeds of the facility will be used for general corporate purposes, including refinancing of the public debt maturities upcoming in Q1 2021.  

In March and April, the Group also added RUB20 billion to its cash cushion by utilisation of its committed and uncommitted credit lines in Russia, due 2023.

The first sizeable maturities are due in Q1 2021 which should be comfortably covered by our existing cash balances and committed credit facilities.

Despite Covid-19 related challenges and market downturns, EVRAZ remains committed to its long-term strategic goals, sustainability principles and high standards of corporate governance and control.

 

For more information, please contact:

 

Investor Relations

Tel: +7 495 232 1370

Email: ir@evraz.com

 

Media Relations

Tel: +7 495 937 6871

Email: media@evraz.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUAGCUPUGPQ
Date   Source Headline
29th May 20181:08 pmRNSTransaction announcement and GM notice
24th May 201812:09 pmRNSInterim dividend for 2018
14th May 20185:07 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSDirector/PDMR Shareholding
10th May 20186:00 pmRNSHolding(s) in Company
8th May 20188:43 amRNSNotice of 2018 AGM
4th May 201812:18 pmRNSTransfer of shares out of treasury, Voting rights
26th Apr 20187:00 amRNSEVRAZ Q1 2018 TRADING UPDATE
5th Apr 20187:00 amRNSDirector/PDMR Shareholding
16th Mar 20187:00 amRNSDirector/PDMR Shareholding
14th Mar 20189:51 amRNSDividend - Determination of Currency Amounts
13th Mar 20181:22 pmRNSDirector/PDMR Shareholding
5th Mar 20186:00 pmRNSAmendment of existing loan agreements
1st Mar 20188:53 amRNSTransaction announcement
1st Mar 20187:00 amRNSAnnual Financial Report
22nd Feb 201812:40 pmRNSNOTICE - FY2017 RESULTS, CONFERENCE CALL DETAILS
18th Jan 20187:00 amRNSQ4 and FY 2017 production report
18th Oct 20177:00 amRNSEVRAZ plc holds Investor Day
17th Oct 20177:00 amRNSQ3 2017 production report
26th Sep 20173:15 pmRNSDirector/PDMR Shareholding
14th Sep 201710:25 amRNSDirector/PDMR Shareholding
5th Sep 20175:13 pmRNSDirector/PDMR Shareholding
24th Aug 20172:57 pmRNSInterim Dividend Determination of Currency Amounts
10th Aug 20179:55 amRNSCorrection to Dividend Payment Currency Inform-on
10th Aug 20177:00 amRNSHalf-year Report
27th Jul 20176:00 pmRNSNOTICE - H1 2017 RESULTS & CONFERENCE CALL DETAILS
19th Jul 20177:00 amRNSQ2 2017 production report
20th Jun 201712:51 pmRNSResult of AGM
15th Jun 20174:16 pmRNSCompletion of disposal of Nakhodka Trade Sea Port
7th Jun 201711:33 amRNSEVRAZ supply chain transparency statement
2nd Jun 20172:30 pmRNSReport on payments to governments for 2016
31st May 20176:00 pmRNSTotal Voting Rights
26th May 20175:21 pmRNSTransaction announcement
23rd May 201710:42 amRNSResults of the General Meeting
15th May 20172:30 pmRNSNotice of 2017 AGM
12th May 20179:51 amRNSHolding(s) in Company - CORRECTED
11th May 20176:00 pmRNSHolding(s) in Company
11th May 201710:25 amRNSDirector/PDMR Shareholding
4th May 20177:00 amRNSTransfer of shares out of treasury, Voting rights
3rd May 20171:08 pmRNSPublication and Posting of Shareholder Circular
3rd May 20177:00 amRNSTransaction announcement
27th Apr 20177:00 amRNSEVRAZ - PARTIAL REDEMPTION OF 7.5% NOTES DUE 2019
20th Apr 20177:03 amRNSQ1 2017 production report
14th Mar 20177:00 amRNSEVRAZ priced U.S.$750 million note issue
1st Mar 20177:00 amRNSAnnual Financial Report
22nd Feb 20176:00 pmRNSNOTICE OF FY 2016 RESULTS
19th Jan 20177:00 amRNSQ4 and FY 2016 production report
3rd Jan 20171:00 pmRNSDirector/PDMR Shareholding (CORRECTED)
30th Dec 201612:39 pmRNSDirector/PDMR Shareholding
29th Dec 20161:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.